Pediatric Cancer Survivors Experience Premature Aging
Young adult survivors of pediatric cancer experience significant premature aging, a retrospective study suggests.
Diagnosis & Disease Information
Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity
The approval was based on data from 2 pivotal phase 3 trials, which evaluated Pedmark in pediatric patients undergoing treatment with cisplatin-based chemotherapy.
Phthalates in Medications May Increase Risk of Childhood Cancers
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
3MT Gene Signature May Predict Poor Outcomes in Neuroblastoma
Elevated urinary 3MT levels were tied to worse event-free and overall survival.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
FDA Rejects Pedmark NDA Again Citing Manufacturing Deficiencies
The application could not be approved in its present form due to manufacturing deficiencies.
Frailty Linked to Neurocognitive Decline in Young Adult Survivors of Childhood Cancer
Frail survivors of childhood cancer experienced greater neurocognitive decline.
Lymphoseek Approval Expanded to Pediatric Patients
The approval was based on data from a phase 2 trial that assessed Lymphoseek in pediatric patients with melanoma, RMS, or other solid tumors.
- Loading...
Loading...
Next post in News
Loading... 
Loading...